RWA
Redhawk Wealth Advisors’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-21,361
| Closed | -$1.84M | – | 322 |
|
|
2024
Q4 | $1.84M | Buy |
21,361
+2,406
| +13% | +$207K | 0.25% | 82 |
|
|
2024
Q3 | $2.26M | Sell |
18,955
-372
| -2% | -$44.3K | 0.32% | 75 |
|
|
2024
Q2 | $2.76M | Buy |
19,327
+2,314
| +14% | +$330K | 0.42% | 56 |
|
|
2024
Q1 | $2.18M | Buy |
17,013
+4,206
| +33% | +$540K | 0.36% | 61 |
|
|
2023
Q4 | $1.32M | Buy |
12,807
+651
| +5% | +$67.3K | 0.26% | 87 |
|
|
2023
Q3 | $1.11M | Buy |
12,156
+6,766
| +126% | +$615K | 0.37% | 64 |
|
|
2023
Q2 | $872K | Buy |
5,390
+1,874
| +53% | +$303K | 0.27% | 82 |
|
|
2023
Q1 | $560K | Buy |
3,516
+591
| +20% | +$94.1K | 0.19% | 103 |
|
|
2022
Q4 | $396K | Buy |
+2,925
| New | +$396K | 0.15% | 130 |
|